Drugs · acquisition-cost intelligence
7 Select Maximum Strength
Acetaminophen, Dextromethorphan Hydrobromide, Guaifenesin, and Triprolidine Hydrochloride· ingredient dextromethorphanExpectorants· DEXTROMETHORPHAN HYDROBROMIDE 20 mg/1; GUAIFENESIN 400 mg/1; DEXTROMETHORPHAN HYDROBROMIDE 20 mg/20mL; GUAIFENESIN 400 mg/20mL; DEXTROMETHORPHAN HYDROBROMIDE 2.5 mg/2.5mL; GUAIFENESIN 50 mg/2.5mL; DEXTROMETHORPHAN HYDROBROMIDE 5 mg/5mL; GUAIFENESIN 100 mg/5mL
What this is. Acquisition-cost intelligence for pharmacy & clinic buyers — the historical trend, generic-equivalent costs, and Part D posture. NADAC is a pharmacy acquisition cost (the national average pharmacies pay), not a retail or cash price — for consumer cash prices use GoodRx/your plan.
Acquisition benchmark · NADAC per ML
$0.02142
NADAC — pharmacy acquisition cost, not a retail/cash price
Acquisition-cost history
Weekly NADAC per ML — the trend nobody else shows. 6 weeks.
2025-12-172026-05-20
Same-ingredient options by acquisition cost
Other dextromethorphan products, cheapest acquisition cost first. Per ML — confirm strength/form equivalence before switching.
| Product | NADAC / ML | vs this |
|---|---|---|
| ACTINEL Diabetic | $0.01104 | −$0.01040 |
| adult cough and chest congestion | $0.01973 | −$0.00170 |
| BACTIMICINA COUGH AND COLD | $0.02085 | −$0.00060 |
| Adult Cough Relief | $0.02292 | +$0.00150 |
| Promethazine DM | $0.03852 | +$0.01710 |
| AMAZON Childrens Multi Symptom Cold | $0.04678 | +$0.02540 |
| 12 HR RELIEF COUGH DM | $0.06804 | +$0.04660 |
| VANACOF DM | $0.06956 | +$0.04810 |
Sources: CMS NADAC (pharmacy acquisition cost), FDA NDC + RxNorm (identity), RxClass (therapeutic class), CMS Medicare Part D formulary (coverage). Observed reference data for professional buyers — not a retail/cash price, not pricing or medical advice. Verify before purchasing or substituting.